Diagnostic work-up for the detection of malnutrition in hospitalized cancer patients C ancer patients are at high risk of developing malnutrition because of their consumptive disease and therapy-related side efects. 1 Te incidence of malnutrition in hospitalized cancer patients ranges between 38% and 71%. 2, 3 In tumor patients in particular, weight loss is associated with an unfavorable prognosis, reduced quality of life, increased chemotherapy-toxicity, and a diminished response to therapy. 4 However, there is neither a uniform and accepted defnition of malnutrition, nor an internationally recognized reference method for the assessment of malnutrition in terms of a gold standard. [5] [6] [7] Tese facts complicate the diagnosis of malnutrition and a timely intervention to counteract the loss of body mass.
In this study, we compared the diferent methods for measuring nutritional status and identifying malnutrition in patients with hematologic and oncologic diseases. Te nutritional status of eligible patients was assessed using the Nutritional Risk Screening 2002 (NRS-2002), a comprehensive bioimpedance analysis (BIA), and the measurement of laboratory parameters that refect the serum visceral protein level (albumin, pre-albumin, and retinol-binding protein [RBP] ). We also evaluated the practicability and feasibility of these methods in the hospital setting.
Methods
Tis single-center, non-interventional reliability study was carried out at the University Hospital of the Martin-Luther-University Halle-Wittenberg, Germany. Te study protocol was approved by the local ethics committee, and eligible patients had to sign an informed consent before enrollment. Patients were included if they were aged ≥18 years and hospitalized for the beginning or the continuation of chemotherapy during the study period. Patients were ineligible for the following reasons: known drug or alcohol abuse, severe active infections, severe chronic or infectious diseases, abnormal laboratory values (aspartate aminotransferase, >2. 5 
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Accepted for publication February 4, 2016 Background Malnutrition is a common complication in patients suffering from cancer. It is associated with a poor prognosis, reduced quality of life, increased chemotherapy-induced toxicity, and a decreased response to therapy. Objective To evaluate and compare the use of various diagnostic tests for the detection of malnutrition in patients hospitalized for cancer treatment. Methods In this single-center, non-interventional reliability study, the nutritional status of 50 patients with cancer was assessed using the Nutritional Risk Screening (NRS-2002), a bioimpedance analysis (BIA), and the measurement of laboratory parameters that refect the serum visceral protein level. For statistical analysis, the comparison of means and the agreement of the methods were calculated. Results NRS-2002, BIA, and lab parameters differed widely among patients classifed as well-nourished or malnourished (10%-80%, depending on the method). Signifcant results in the comparison of means were observed for body mass index, serum protein, and some BIA parameters. The analysis of agreement identifed a compelling agreement for pre-albumin and retinol-binding protein (RBP) (kappa = 0.81). Limitations Small sample size, heterogeneous group of patients, non-interventional reliability study. Conclusion The tested diagnostic methods for detecting malnutrition did not have an evident agreement among each other with a limited exchangeability. In routine hospital practice several methods should be applied in order to identify cancer patients at risk of malnutrition. Funding/sponsorship Fresenius Kabi provided the BIA-unit and software. 8 Tis score also measures the individual risk of developing malnutrition because of disease and concomitant circumstances. It consists of a prescreeningincluding questions for body-mass index (BMI), weight loss, reduced food intake, and severity of disease -and a mainscreening allowing a graduation of the nutritional disorder and the severity of the disease if one question of the prescreening is answered positively. Using a sum score the overall risk to develop malnutrition can be assessed (0, no risk; 1-2, moderate risk; 3-7, high risk).
Laboratory parameters refecting the serum visceral protein level -albumin, pre-albumin and RBP -were determined in the next blood sample as parameters for the nutritional status and, if applicable, the severity of an existing malnutrition. Reference values for each parameter are in Table 1 . 9 To estimate the body composition of each patient, BIA was conducted at least 1 hour after the last meal or liquid intake. BIA unit (BIACORPUS RX 4000), electrodes (BIAphaser Tabs) and software (BodyComp V8.5) were produced by MEDICALHealthCare GmbH; Karlsruhe, Germany. Te software for calculating the body compartments is commonly recommended for the use in epidemiological studies. 10 Te following values were obtained: resistance (R), reactance (Xc), phase angle, fat-free mass, fat mass, body cell mass (BCM), extracellular mass (ECM), ECM:BCM ratio.
Statistics
Te data analysis was carried out using BIAS for Microsoft Windows (version 9.16). Results were considered to be statistically signifcant at a P value of ≤.05. Patient data were described using mean value, standard deviation, and range. For statistical analysis, patients were divided into groups according to the reference values for each method: patients whose values were in the reference range were classifed as well nourished. Patients with values below the reference values were classifed as malnourished. Furthermore, for the laboratory parameters and the NRS-2000 subdivisions refecting the severity of malnutrition were established. Te Kolmogorov-Smirnov test, modifed by Dallal and Wilkinson, 11 was used to test normal distribution of the data. For comparison of 2 independent, normally distributed samples the t test was used, for not normally distributed data the Wilcoxon-Mann-Whitney-U-Test. To compare more than 2 independent samples the single factor variance analysis and for not normally distributed data the Kruskall-Wallis test were conducted. 12 To determine the agreement between 2 methods and to assess the interrater-reliability regarding categorical parameters, Cohen´s kappa was used.
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Results
Patient characteristics
A total of 50 patients (23 women and 27 men) with solid tumors and hematologic malignancies were included in the study during August 2012-January 2013 (Table 2) .
Nutritional status
Te nutritional status of cancer patients was assessed with the NRS-2002, laboratory values, BIA, and the BMI, using their respective reference values to categorize the patients as well nourished or malnourished (Table 3 ). Te severity of malnutrition was evaluable by the NRS-2002 and albumin, pre-albumin, and RBP levels. Te phase angle and the ECM:BCM ratio -both widely accepted predictors for the clinical progress of malnutrition -were used for the analysis of BIA.
Te number of patients classifed as well nourished and malnourished difered considerably between these diagnostic tests (10%-80%, depending on the method).
To assess the agreement between the diferent methods, the kappa-coefcient was calculated (Table 4) . Te NRS-2002. Te comparison of means showed no signifcant diferences for patients classifed under no, moderate, or high risk for develop malnutrition on the basis of their achieved point value. In the next step, patients with moderate and high risk were summed up to investigate whether they difered signifcantly from patients without risk. However, this comparison of means showed no signifcant diferences between the 2 groups (P ≤ .05).
Body-mass index. A statistically signifcant correlation was observed for percentage of fat-free mass and percentage of fat mass: obese and overweight patients had signifcantly lower percentage of fat-free mass and a higher percentage of fat mass than did patients with normal weight (fat free mass: 66.76% overweight vs 79.64% normal weight; fat mass: 33.05% overweight vs 20.35% normal weight; P ≤ .05). 
Discussion
Tere is an unmet medical need for a standardized reference method for the detection of malnutrition in cancer patients that would be realistically applicable the in clinical routine. We compared the common diagnostic tests and studied the agreement among the diferent methods; a clinical preferable method could not be confrmed by this trial.
Te NRS-2002 screening is suitable for assessing a patient's risk of sufering from malnutrition based on the detection of existing nutritional problems. Patients are identifed when presenting with a BMI <20.5 kg/m 2 , unintentional weight loss in the previous 3 months, decreased food intake in the past week, or serious illness.
Te determination of laboratory parameters and body composition using bioimpedance analysis is appropriate to quantify the extent of an existing malnutrition. Terefore, the aforementioned methods are used at diferent points in the diagnosis of malnutrition. Although the NRS-2002 should be applied as part of the routine screening to identify patients at risk, the determination of laboratory parameters and body composition should be used for fur- Compared with the other methods used, the BMI alone is not sufcient to refect the nutritional status of a patient, because weight loss, decreased serum protein, and altered body composition could not be recognized. For example, in patients sufering from body water disorders, weight loss can be masked. 5 For this reason, the interpretation of the BMI as a single parameter has to be done carefully with regard to other parameters and patients´ history. Te sole use of the BMI for the diagnosis of malnutrition cannot be recommended and it should no longer be a marker of malnutrition in clinical practice.
In the present study, the laboratory parameters albumin, pre-albumin, and RBP were determined to refect the nutritional status of the patients. Te interpretation of these values should be made in regard to further diagnoses, for example, liver and kidney dysfunction and increased infammatory parameters. 14, 15 For this reason, patients with liver and kidney dysfunction and increased infammatory parameters were excluded from participation in this study.
Albumin is generally accepted as a strong marker of the nutritional status. 16 In some studies, low albumin has been associated with prolonged hospital stay, increased complications, and mortality. [17] [18] [19] Te disadvantage of albumin is that the protein has a relatively long half-life (18-20 days), and its change in concentration depends on the patient's body water balance. Terefore, the parameter is not considered to be sensitive enough to reliably diagnose malnutrition. 20 Because the serum protein concentration can be maintained over a long period of reduced food intake or fasting at the expense of skeletal muscle mass, a reduction of muscle strength may occur even before changes in the plasma protein develop. 21 Consequently, changes in body composition can occur before a shift of the serum protein concentration, which explains the low agreement between albumin levels and the data of the bioimpedance analysis in the present study.
Albumin levels should be used only for the verifcation of a suspected malnutrition or to estimate the extent of an existing malnutrition, carefully considering the halflife of the protein and the further diagnoses of the patient. Meanwhile, low albumin levels, regardless of the underlying cause, remain an independent prognostic factor for the overall survival of cancer patients. 22 Because albumin has a short half-life of about 2 days, pre-albumin levels react quickly to changes of the food supply and are therefore suitable to refect the nutritional status of a patient and to determine the success of a nutritional intervention. In case of insufcient food intake, the plasma concentration of pre-albumin decreases signifcantly after 3 days. 23 On the one hand, the synthesis rate of pre-albumin depends on the nutritional intake of protein: sufcient supply increases pre-albumin plasma levels by 1 mg per day. 24 On the other hand, the serum concentration of pre-albumin -an acute phase protein -is elevated in severely ill patients with high infammatory parameters. 25 In the present study, 7 patients were classifed as malnourished with pre-albumin values ≤ 0.15 g/L. Pre-albumin and RBP have a very good agreement and identifed the same 5 patients in the study as malnourished. Pre-albumin testing classifed 2 additional patients as malnourished. Both methods are interchangeable in the diagnosis of malnutrition, so the determination of both parameters in the clinical setting is not reasonable and economic. If the results are interpreted with regard to kidney or liver disease or infammation of the patient, then pre-albumin is a reliable marker to identify malnutrition. 20 In the present study, BIA was used to determine the body composition of the patient. BIA is easy to use, noninvasive, inexpensive, and requires little patient cooperation, so this method is also suitable for geriatric or severely impaired patients. 26 In the process of malnutrition, fat-free mass and fat mass degrade and a shift in the balance of the body compartments can be observed. 27 Te bioimpedance analysis is particularly suitable for serial measurements, so that weight loss or gain can be assigned to the diferent body compartments even though tumor mass or water retention masks the loss of body weight. Multifrequent BIA-measurements allow the determination of hydration and identify fuid imbalances. Te amount of total body water is refected by body cell mass, a high ECM:BCM index and low musclecell ratio represent edema or ascites. Furthermore, imbalances are also well refected by the raw data (phase angle, reactance, resistance). With respect to these parameters, patients' water-balance can be interpreted.
Because the phase angle is also a good predictor of clinical outcome, 28 we determined it to assess the nutritional status of the study patients, and we used age-, gender-and BMI-specifc reference values from Bosy-Westphal and colleagues to evaluate the results. 29 In the present study, 17 patients were classifed as malnourished with a phase angle ≤5th percentile. Te comparison of means was not signifcant and the analysis of agreement showed weak agreement for albumin, prealbumin and RBP and a low agreement for NRS-2002 and ECM:BCM. In patients with lung or colon cancer or HIV, the phase angle has been described as a prognostic marker for mortality. [30] [31] [32] It is hypothesized that the phase www.jcso-online.com
Original Report angle acts as a surrogate marker of catabolic processes and is therefore an independent prognostic marker of clinical course and mortality. 32 Norman and colleagues showed that disease-associated weight loss is accompanied by loss of body cell mass and dysfunction of cell membrane integrity and is associated with a decreased number of intact cell membranes. 28 In addition, the amount of fat-free mass has a prognostic signifcance, because it is associated with longer hospital stay, 33 decreased immune function, and increased mortality. 34 In healthy, normally hydrated persons, the amount of BCM is greater than the amount of ECM, so that the ratio ECM:BCM is <1. In individuals with disturbance of body water balance or in the catabolic state, this ratio shifts and reaches values >1. In the present study, the comparison of means showed that patients with an ECM:BCM ratio >1 had signifcantly lower pre-albumin, lower phase angle and a decreased cell content than patients with a normal ECM:BCM ratio. In the analysis of agreement only a weak agreement between ECM:BCM ratio and phase angle was observed. Since the statement of the ECM:BCM ratio on the nutritional status of a patient is limited due to body water balance disturbances, the interpretation of the ratio should be done in view of the overall condition of the patient. However, it should be considered that the reason for body water disturbances in severely malnourished patients is often the loss of serum protein, especially albumin.
Patients were included regardless of their primary diagnosis and tumor stage which might be a limitation of this study. On the other hand, our trial is the frst that proved the comparability of diferent diagnostic tests assessing the nutritional status in the routine setting of a University hospital for Hematology and Oncology. Other trials have been limited to patients with a particular entity, for example patients with lung cancer. 35 
Conclusion
We were not able to identify a single method that is reliable and applicable enough to be a reference tool in the diagnostic work-up for the identifcation of undernourished patients or those at risk of malnutrition. We therefore advise to implement one of the established screening questionnaires to detect patients with general nutritional problems in the clinical routine and to determine serum proteins with a short half-life (pre-albumin or RBP). Tose methods for the identifcation of body composition (eg, BIA) are suitable for a more subtle diagnostic work-up, and these methods might be appropriate to monitor the success of a nutritional therapy, but not applicable in most facilities. Te sole determination and interpretation of the BMI is not recommendable, because protein-energy-malnutrition could not be detected by this parameter. Eligible methods should be selected and implemented in respect of available resources. In undernourished patients nutritional intervention should be considered from the beginning as a part of the tumor treatment to maintain or to improve the nutritional status of patients who are unable to meet a sufcient caloric requirement.
